Stay updated on Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now shows an added Revision: v3.4.2 and the removal of the older funding-status notice (Revision: v3.4.1).SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide funding-lapse notice was added and the release version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.7%

- Check28 days agoChange DetectedMinor UI and metadata updates include a new 'Show glossary' option and color-coded change indicators (green for additions and red for deletions). The revision label was updated to v3.4.0 and 'No FEAR Act data' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedThe history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page.